Session Information
ASHP Summer Meeting 2006
Click here to go to the previous page
Tuning Up Your Plan for USP <797>, Part I
Track:
Sessions
Program Code: 108-L04
Date: Wednesday, June 28, 2006
Time: 8:00 AM to 11:00 AM
SPEAKER(S):
Mr. Eric Kastango, MBA, RPh, President/CEO, Clinical IQ, LLC
Keith H. St. John, M.S., M.T., Director, Infection Control/Prevention, Children's Hospital of Philadelphia
Laura A. Thoma, Pharm.D., Associate Professor, University of Tennessee
James T. Wagner, President, Controlled Environment Consulting
Description
Learning Objectives:
Explain the USP change process and the methods used to establish the proposed changes.
Summarize key changes proposed for the next USP <797> and their implications.
Explain the evidence-based science behind the proposed changes in USP <797>.
Discuss the importance of employee training in order to create a robust compounding operation.
Explain the USP change process and the methods used to establish the proposed changes.
Summarize key changes proposed for the next USP <797> and their implications.
Explain the evidence-based science behind the proposed changes in USP <797>.
Discuss the importance of employee training in order to create a robust compounding operation.
| No items are available for this session. |